Biogen Pharmachem Industries Limited

Submitted Annual Report for FY 2025-26 to BSE with AGM scheduled for September 29, 2026, through video conferencing. Reported net profit of ₹95.67 lakh on total income of ₹255.80 lakh, with significan

Biogen Pharmachem Industries issued notice for its 31st Annual General Meeting to be held via video conference on September 29, 2026. AGM agenda includes adopting FY26 financial statements, re-appoint